Susquehanna International Group
TNYA icon

Susquehanna International Group’s Tenaya Therapeutics TNYA Stock Holding History

Susquehanna International Group’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$214K Buy
308,772
+24,185
+8% +$17.8K ﹤0.01% 11556
2025
Q4 		$202K Sell
284,587
-70,152
-20% -$95.4K ﹤0.01% 10850
2025
Q3 		$575K Buy
354,739
+45,833
+15% +$46.2K ﹤0.01% 8657
2025
Q2 		$189K Buy
308,906
+181,946
+143% +$92.6K ﹤0.01% 11270
2025
Q1 		$72.4K Sell
126,960
-19,802
-13% -$19.5K ﹤0.01% 11728
2024
Q4 		$210K Buy
146,762
+136,423
+1,319% +$306K ﹤0.01% 10631
2024
Q3 		$20K Sell
10,339
-32,679
-76% -$92.3K ﹤0.01% 11626
2024
Q2 		$133K Sell
43,018
-11,435
-21% -$47.2K ﹤0.01% 10813
2024
Q1 		$285K Sell
54,453
-29,870
-35% -$143K ﹤0.01% 9812
2023
Q4 		$273K Buy
+84,323
New +$182K ﹤0.01% 10017
2023
Q3 		– Sell
-71,568
Closed -$420K – 12988
2023
Q2 		$420K Buy
71,568
+10,915
+18% +$63.4K ﹤0.01% 8719
2023
Q1 		$173K Buy
60,653
+40,053
+194% +$113K ﹤0.01% 10773
2022
Q4 		$41.4K Buy
+20,600
New +$50.3K ﹤0.01% 11489

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group's TNYA Position: Q1 2026 in Review

Susquehanna International Group increased its Tenaya Therapeutics (TNYA) stake by 8.5% in Q1 2026, buying an estimated $17.8K and bringing the position to 308,772 shares worth $214K. The position accounts for ﹤0.01% of the portfolio, ranked #11556.

Susquehanna International Group first reported a position in TNYA in Q4 2022 and has held it in 13 quarters since. The position peaked at $575K in Q3 2025. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Susquehanna International Group held 308,772 shares of Tenaya Therapeutics worth $214K as of Q1 2026.
  • Susquehanna International Group bought 24,185 Tenaya Therapeutics shares in Q1 2026, an estimated $17.8K.
  • Tenaya Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11556 holding.
  • Susquehanna International Group first reported a position in Tenaya Therapeutics in Q4 2022 and has held it in 13 quarters since.
  • Susquehanna International Group's Tenaya Therapeutics position peaked at $575K in Q3 2025.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.